Musculoskeletal Disease Articles & Analysis
1 articles found
These results support the use of abaloparatide as the initial treatment in sequential therapy with ALN in women with PMO at very high fracture risk, a treatment paradigm consistent with recently updated clinical practice guidelines from organizations such as American Association of Clinical Endocrinology (AACE) and European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis ...